ERBB2 and breast cancer: Systematic therapies include chemotherapy, anti-HER2 treatment for HER2+ BC, bone-stabilizing agents, endocrine therapy for hormone receptor-positive breast cancer, poly(ADP-ribose) polymerase inhibitors for patients with BRCA mutation, and immunotherapy [4].